GATA3 and colon carcinoma: The MAPK-ERK pathway activation was found to prevent the proteasome-dependent degradation of Fos-related antigen 1 (FRA-1) protein in colon carcinoma cells [34] and GATA3 protein in developing Th2 cells [35].